Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3034368	li-hhv6abm	— (—)	283	294	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of the central nervous system

23.99

72.66

1.0

—

Viral infections of the central nervous system

23.84

55.68

1.1

1.0

—

Neurological diseases

8.10

51.31

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

151

4.32

32.52

1.1

1.0

—

Neurological diseases, wide definition

13.01

29.78

1.1

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

138

4.79

29.55

1.0

—

Encephalitis

58.42

29.26

1.1

1.0

—

Other encephalitis

56.77

28.30

1.1

1.0

—

Headache

105

5.02

28.03

1.1

1.0

—

Other symptoms and signs involving cognitive functions and awareness

6.13

26.87

1.1

1.0

—

General symptoms and signs

112

4.07

25.96

1.1

1.0

—

Convulsions, not elsewhere classified

7.47

25.86

1.1

1.0

—

Fever of other and unknown origin

5.17

23.41

1.1

1.0

—

Other degenerative diseases of the nervous system

12.15

20.52

1.0

—

Episodal and paroxysmal disorders

152

3.24

20.48

1.1

1.0

—

Malaise and fatigue

5.08

18.99

1.0

—

Meningitis

29.06

17.42

1.0

—

Other bacterial diseases

156

3.24

17.34

1.1

1.0

—

Care involving use of rehabilitation procedures

154

3.52

16.85

1.1

1.0

—

Epilepsy

4.58

16.68

1.1

1.0

—

Bacterial infection, other or unspecified

4.23

16.51

1.1

1.0

—

Other neurological diseases

117

3.65

15.76

1.0

—

Disturbances of skin sensation

5.18

15.29

1.1

1.0

—

Certain infectious and parasitic diseases

111

3.21

14.91

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7.66

14.75

1.1

1.0

—

Visual disturbances and blindness

141

3.48

14.49

1.0

—

STROKE

3.79

14.37

1.1

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

4.03

14.20

1.1

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

10.02

14.00

1.0

1.1

—

Visual disturbances

127

3.47

12.99

1.0

—

ILD medications: immunosuppressive drugs

161

3.10

12.72

1.1

1.0

—

First line medication for Crohn's disease

171

2.62

12.70

1.1

1.0

—

Status epilepticus

24.55

12.47

1.0

—

Non-invasive ventilation

5.51

12.40

1.0

—

Cerebrovascular diseases

106

3.31

12.32

1.0

—

Persons encountering health services for specific procedures and health care

184

2.59

12.21

1.1

1.0

—

Dizziness and giddiness

120

3.25

12.15

1.1

1.0

—

Organic, including symptomatic, mental disorders

4.15

11.98

1.0

—

Demyelinating diseases of the central nervous system

7.42

11.84

1.1

1.0

—

Cerebrovascular diseases (FINNGEN)

4.30

11.77

1.1

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

175

2.90

11.27

1.1

1.0

—

Nausea and vomiting

4.02

11.25

1.0

—

Pain (limb, back, neck, head abdominally)

3.00

11.10

1.1

1.0

—

Psychiatric diseases

144

2.54

10.48

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

4.63

10.45

1.1

1.0

—

ILD medications

185

2.37

10.32

1.1

1.0

—

GASTRO-related operations

111

2.76

10.21

1.1

1.0

—

Any gastric operation

111

2.76

10.21

1.1

1.0

—

Stroke, including SAH

3.28

9.83

1.1

1.0

—

Second line medication for Crohn's disease

158

2.85

9.69

1.2

1.0

—

Implicit Sepsis

128

2.86

9.57

1.1

1.0

—

Migraine with aura

4.59

9.51

1.1

1.0

—

Stroke, excluding SAH

3.24

9.16

1.1

1.0

—

Abnormalities of gait and mobility

5.50

8.96

1.1

1.0

—

Focal epilepsy

3.64

8.96

1.0

—

L04AX Other immunosuppressants

154

2.79

8.96

1.1

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.80

8.49

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

177

2.27

8.44

1.1

1.0

—

Focal epilepsy, strict definition

3.67

8.42

1.0

—

Other disorders of eye and adnexa

4.65

8.34

1.1

—

Dorsalgia

143

2.39

8.28

1.0

—

Dental caries

3.52

8.24

1.1

1.0

—

Viral meningitis

14.56

8.20

1.2

1.0

—

Influenza and pneumonia

205

2.21

8.10

1.0

—

Ischaemic Stroke, excluding all haemorrhages

3.23

7.97

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

155

2.44

7.76

1.1

1.0

—

Persons encountering health services for examination and investigation

2.71

7.72

1.1

1.0

—

Subjective visual disturbances

3.87

7.68

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

3.86

7.68

1.1

1.0

—

MS-disease / Multiple Sclerosis

6.69

7.60

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

3.85

6.97

1.0

—

Migraine

113

2.71

6.92

1.1

1.0

—

Other dorsopathies, not elsewhere classified

145

2.22

6.86

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

3.50

6.70

1.1

1.0

—

Inflammatory bowel disease treatment related agents

194

2.05

6.64

1.1

1.0

—

Viral Sepsis

3.71

6.62

1.2

1.0

—

Intracranial trauma

3.45

6.62

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

12.29

6.58

1.0

1.1

—

Extrapyramidal and movement disorders

3.10

6.57

1.0

—

Mood disorders, excluding more controls

143

2.26

6.46

1.1

1.0

—

Deposits [accretions] on teeth

4.12

6.40

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

145

2.14

6.36

1.1

1.0

—

Any mental disorder

155

2.10

6.35

1.1

1.0

—

Other and unspecified polyneuropathies, also in other diseases

4.05

6.34

1.1

1.0

—

Pain in throat and chest

141

2.25

6.34

1.1

1.0

—

Diseases of the eye and adnexa

129

2.21

6.31

1.1

1.0

—

Symptoms and signs concerning food and fluid intake

5.46

6.27

1.0

—

Abnormal involuntary movements

4.42

6.23

1.0

—

Diseases of the respiratory system

2.48

6.19

1.1

1.0

—

Oral corticosteroids

173

2.10

6.17

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

169

2.12

6.15

1.1

1.0

—

Pure hypercholesterolaemia

2.56

6.05

1.0

—

Explicit Sepsis

2.83

6.01

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

149

2.19

5.98

1.0

—

149

2.19

5.98

1.0

—

Concussion

3.53

5.97

1.0

—

Excluding asthma or asthma-COPD overlap

107

2.29

5.90

1.1

1.0

—

Implicit viral Sepsis

3.52

5.87

1.2

1.0

—

Dentinal caries

3.27

5.79

1.0

—

All pneumoniae

205

2.02

5.79

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

174

2.02

5.76

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

181

1.99

5.75

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

162

2.01

5.73

1.1

1.0

—

Enlarged lymph nodes

4.65

5.73

1.2

1.0

—

Anxiety disorders, excluding more controls

140

2.23

5.72

1.1

1.0

—

Cerebral palsy and other paralytic syndromes

3.91

5.70

1.0

—

Transient ischemic attack

2.91

5.70

1.0

—

All influenza

3.03

5.63

1.0

1.1

—

Cerebral cysts

5.90

5.63

1.1

1.0

—

Postprocedural disorders of nervous system

5.90

5.62

1.0

1.1

—

Other and unspecified nonorganic psychotic disorders

3.40

5.57

1.0

—

COPD/asthma/ILD related infections

150

2.04

5.56

1.1

1.0

—

COPD/asthma related infections

150

2.04

5.56

1.1

1.0

—

Diplopia

4.25

5.55

1.0

—

Other pulmonary diagnosis

107

2.25

5.54

1.1

1.0

—

COPD differential diagnosis

107

2.25

5.54

1.1

1.0

—

ILD differential diagnosis

107

2.25

5.54

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

205

1.99

5.52

1.0

—

Depression

185

2.05

5.52

1.1

1.0

—

Septicaemia

2.78

5.44

1.1

1.0

—

Autoimmune diseases related-to ILD

201

2.10

5.42

1.0

—

Other septicaemia

2.87

5.36

1.1

1.0

—

Hypothyroidism (congenital or acquired)

3.45

5.35

1.0

—

Neoplasms

139

2.08

5.33

1.1

—

Dorsopathies

156

2.00

5.32

1.1

1.0

—

Bacterial meningitis

11.32

5.29

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

202

1.99

5.25

1.1

1.0

—

Mood disorders

189

1.98

5.20

1.1

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

199

1.98

5.17

1.0

—

Abdominal and pelvic pain

145

2.01

5.16

1.1

1.0

—

Abnormalities of breathing

162

2.02

5.15

1.1

1.0

—

Speech and linguistic disorders, excluding more controls

3.83

5.13

1.1

1.0

—

Malignant neoplasm, wide definition for exclusion

138

2.10

5.08

1.1

1.0

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

138

2.10

5.08

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

123

2.41

5.05

1.0

—

Low back pain

129

2.27

5.05

1.0

—

Speech disturbances, not elsewhere classified

5.28

5.04

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.33

5.03

1.1

1.0

—

Neurotic, stress-related and somatoform disorders

184

2.01

5.03

1.1

1.0

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

139

2.08

5.00

1.1

1.0

—

Bacterial Sepsis

2.71

4.95

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

123

2.44

4.93

1.1

1.0

—

Anxiety disorders

185

1.99

4.92

1.1

1.0

—

Diseases of oral cavity, salivary glands and jaws

144

2.00

4.92

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

2.33

4.86

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

109

2.25

4.86

1.1

1.0

—

Mood [affective] disorders

190

1.94

4.84

1.1

1.0

—

Syncope and collapse

2.95

4.83

1.1

1.0

—

Dermatitis and eczema

213

1.88

4.81

1.0

—

Hypothyroidism, levothyroxine purchases

3.29

4.79

1.1

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.29

4.79

1.1

1.0

—

Other demyelinating diseases of the central nervous system

11.48

4.78

1.1

1.0

—

Polyarthropathies

126

2.17

4.76

1.1

1.0

—

Used for control exclusion in common control thyroid runs

169

1.89

4.76

1.1

1.0

—

Examination and observation for other reasons

2.38

4.74

1.1

1.0

—

Anaemias

3.24

4.68

1.0

—

Any reimbursement code in KELA

2.27

4.68

1.2

1.0

—

Pain in limb

159

2.05

4.62

1.1

1.0

—

Pneumonia, organism unspecified

179

1.98

4.61

1.0

—

Factors influencing health status and contact with health services

3.19

4.60

1.1

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

158

2.20

4.57

1.0

—

Implicit bacterial Sepsis

2.76

4.55

1.1

1.0

—

Schizophrenia or delusion, excluding more controls

2.95

4.48

1.0

—

Dysphagia

3.27

4.46

1.0

—

Medical observation and evaluation for suspected diseases and conditions

2.24

4.45

1.1

1.0

—

Other reaction to severe stress, and adjustment disorders

2.53

4.45

1.1

1.0

—

Type 2 diabetes, wide definition

110

2.19

4.41

1.1

1.0

—

Pain in joint

2.36

4.37

1.0

—

Disorders of optic nerve and visual pathways

3.72

4.36

1.2

1.0

—

Soft tissue disorders

172

1.84

4.34

1.1

1.0

—

Ocular pain

4.56

4.30

1.1

1.0

—

Opioids

130

1.98

4.29

1.1

1.0

—

Other lack of coordination

11.78

4.28

1.1

1.0

—

Oxycodone

2.87

4.27

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

3.88

4.25

1.0

—

Codeine

126

2.01

4.23

1.1

1.0

—

Herpesviral [herpes simplex] infections

3.62

4.20

1.1

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.14

4.20

1.1

1.0

—

Metabolic disorders

162

1.92

4.19

1.1

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

2.76

4.18

1.0

—

Any event in cancer register

142

1.96

4.16

1.1

1.0

—

Strabismus

2.47

4.10

1.0

1.1

—

Dental operations

2.20

4.08

1.1

1.0

—

Other diseases of intestines

195

1.79

4.03

1.0

—

Autoimmune diseases

181

1.78

4.02

1.1

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

136

1.95

4.01

1.0

—

Dental caries, including avohilmo

123

1.95

3.97

1.1

1.0

—

Dental caries 1

123

1.95

3.97

1.1

1.0

—

Other/unspecified dorsalgia

2.74

3.97

1.1

1.0

—

Gastrointestinal diseases

100

2.06

3.94

1.1

1.0

—

Pain, not elsewhere classified

3.13

3.92

1.0

—

Other diseases of upper respiratory tract

180

1.77

3.85

1.0

—

Dental caries 1 and operation codes

136

1.89

3.84

1.1

1.0

—

Injuries to the shoulder and upper arm

177

1.94

3.82

1.0

1.1

—

Weight loss

3.80

1.0

1.1

—

Dissociative [conversion] disorders

8.78

3.77

1.0

—

Cardiovascular diseases

131

1.91

3.75

1.1

1.0

—

Malignant neoplasm

140

1.91

3.71

1.1

1.0

—

Other and unspecified dermatitis

128

2.19

3.68

1.1

1.0

—

Personality disorders, excluding more controls

2.79

3.68

1.1

1.0

—

Exposure to unspecified factor

227

1.78

3.66

1.0

—

Other viral diseases

109

2.29

3.65

1.1

1.0

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.65

3.65

1.0

—

Lower back pain or/and sciatica

187

1.82

3.63

1.0

—

Nonorganic sleeping disorders, excluding more controls

3.25

3.62

1.0

—

Bell's palsy

3.43

3.61

1.2

1.1

—

Type 2 diabetes

146

1.87

3.60

1.0

—

Speech and linguistic disorders

2.85

3.56

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.65

3.55

1.1

1.0

—

Systemic connective tissue disorders

2.50

3.53

1.1

1.0

—

Sequelae of cerebrovascular disease

2.76

3.53

1.1

1.0

—

Nerve, nerve root and plexus disorders

170

1.81

3.53

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

102

2.04

3.51

1.0

—

Benign neoplasms

128

1.90

3.50

1.1

1.0

—

Hard cardiovascular diseases

120

1.98

3.47

1.1

1.0

—

Other (not insulin) diabetes medications

138

1.88

3.44

1.0

—

Biguanides

137

1.89

3.43

1.0

—

Diseases of the skin and subcutaneous tissue

169

1.72

3.37

1.1

1.0

—

Migraine without aura

3.10

3.36

1.1

—

Polyuria

2.83

3.35

1.0

—

Dermatitis

154

2.01

3.33

1.1

1.0

—

Asthma (mode)

107

1.95

3.31

1.0

—

Anxiety (asthma-related co-morbidities)

136

1.97

3.31

1.0

—

Bacterial pneumoniae

2.29

3.31

1.0

—

Diabetes medication

186

1.73

3.30

1.0

—

Venous thromboembolism

105

2.22

3.28

1.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

8.61

3.26

1.5

1.0

—

Other disorders involving the immune mechanism, not elsewhere classified

8.61

3.26

1.5

1.0

—

Arthropathies

166

1.72

3.25

1.1

1.0

—

Gingivitis and periodontal diseases

138

1.80

3.24

1.0

—

Asthma (only as main-diagnosis)

107

1.97

3.23

1.0

—

All anxiety disorders

146

1.93

3.23

1.0

—

Bacterial pneumonia, not elsewhere classified

2.35

3.21

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

3.16

3.21

1.0

1.1

—

Abnormal weight loss

3.58

3.19

1.0

1.1

—

Benign neoplasm of other and unspecified endocrine glands

3.58

3.19

1.0

—

Panic disorder

3.57

3.19

1.1

1.0

—

Caught, crushed, jammed or pinched in or between objects

5.35

3.19

1.1

—

Parasetamol

126

1.82

3.18

1.1

1.0

—

Asthma, excluding more controls

102

1.93

3.14

1.0

—

Fall on same level

211

1.64

3.14

1.0

—

Disorders of adult personality and behaviour

2.47

3.12

1.1

—

Pneumonitis due to solids and liquids

4.51

3.11

1.0

1.1

—

Asthma

107

1.91

3.10

1.0

—

Tramadol

117

1.92

3.07

1.0

—

Dyspnoea

180

1.79

3.06

1.1

1.0

—

Optic neuritis

7.52

3.05

1.2

1.0

—

Disorders of lens

2.04

3.05

1.1

1.0

—

Schizophrenia or delusion

2.38

3.05

1.0

—

Other strabismus

2.32

3.05

1.1

—

Oedema, not elsewhere classified

2.79

3.05

1.1

1.0

—

L04AA Selective immunosuppressants

2.50

3.03

1.1

1.0

—

Other anxiety disorders

111

2.08

3.00

1.1

1.0

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

10.17

2.99

1.2

1.0

—

Acute lymphocytic leukaemia, helper endpoint

10.17

2.99

1.2

1.0

—

Acute lymphocytic leukaemia

10.17

2.99

1.2

1.0

—

Diseases of the ear and mastoid process

189

1.63

2.98

1.0

—

Paraplegia, diplegia of upper limbs

10.05

2.98

1.0

1.2

—

Manic episode

10.03

2.98

1.0

—

Other specified and unspecified disorders of eye and adnexa

10.03

2.98

1.0

1.2

—

Myalgia

2.75

2.98

1.0

—

Schizophrenia, schizotypal and delusional disorders

2.35

2.97

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.40

2.96

1.1

1.0

—

Diseases of pulp and periapical tissues

2.40

2.96

1.0

—

Codes for special purposes

127

2.05

2.95

1.1

1.0

—

Provisional assignment of new diseases of uncertain etiology

127

2.05

2.95

1.1

1.0

—

Personality disorders

2.47

2.95

1.1

1.0

—

Other external causes of accidental injury

127

1.78

2.94

1.0

—

Emotionally unstable personality disorder

3.34

2.90

1.1

1.0

—

Soft tissue disorders related to use, overuse and pressure

2.59

2.87

1.1

1.0

—

Other general symptoms and signs

5.34

2.84

1.1

1.0

—

Other viral diseases, not elsewhere classified

2.29

2.81

1.2

1.0

—

Other functional intestinal disorders

123

2.01

2.81

1.0

—

Substance abuse, excluding more controls

101

2.08

2.78

1.2

1.0

—

Other antidepressants

151

1.69

2.78

1.0

—

Undetermined asthma, excluding more controls

3.91

2.77

1.0

—

Senile cataract

2.07

2.77

1.0

—

Other and unspecified degenerative diseases of nervous system

8.37

2.75

1.2

1.0

—

Bacterial pneumonia (organism specified)

106

2.06

2.75

1.0

—

Systemic atrophies primarily affecting the central nervous system

5.02

2.73

1.0

1.1

—

Certain disorders involving the immune mechanism

2.50

2.69

1.2

1.0

—

Lyme disease

2.50

2.69

1.1

1.0

—

Other spirochaetal diseases

2.50

2.69

1.1

1.0

—

Codeine or tramadol medication

167

1.66

2.68

1.1

1.0

—

Disorders of psychological development

2.43

2.68

1.1

1.0

—

Lymphoid leukaemia

4.22

2.68

1.4

1.0

—

Benign neoplasm of brain and other parts of central nervous system

4.22

2.67

1.0

1.1

—

Post-traumatic stress disorder

4.22

2.67

1.0

—

Cardiac arrhythmias

108

1.90

2.67

1.1

—

Other disorders of optic [2nd] nerve and visual pathways

3.76

2.67

1.1

1.0

—

Diverticular disease of intestine

1.99

2.67

1.0

—

Asthma, unspecified (mode), excluding more controls

2.05

2.64

1.0

—

139

1.93

2.63

1.0

—

Dental caries 1, only avohilmo

131

1.72

2.63

1.0

—

Rheumatoid arthritis

2.34

2.63

1.1

1.0

—

Depression medications

2.45

2.63

1.1

1.0

—

Diabetes mellitus

187

1.63

2.60

1.0

—

Other and unspecified mood [affective] disorders

4.67

2.59

1.1

1.0

—

Symptoms and signs involving the urinary system

146

1.80

2.59

1.1

1.0

—

Benign neoplasms

166

1.65

2.58

1.1

1.0

—

Falls/tendency to fall

187

1.58

2.57

1.0

—

Undetermined asthma

3.60

2.57

1.0

—

Dental pulpitis 2, only avohilmo

117

1.75

2.55

1.1

1.0

—

Immunodeficiency with predominantly antibody defects

7.17

2.55

1.2

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

5.47

2.54

1.0

1.1

—

Migraine with aura and triptan purchases

2.73

2.54

1.2

1.1

—

Chronic sinusitis

2.13

2.53

1.1

1.0

—

Asthma-related infections

168

1.82

2.53

1.0

—

Asthma, hospital admission 2, infections

168

1.82

2.53

1.0

—

Intestinal infectious diseases

225

1.63

2.52

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

175

1.64

2.49

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.32

2.47

1.0

1.1

—

Alcohol abuse, main dg, excluding more controls

2.82

2.47

1.4

1.0

—

Accidents

127

1.70

2.46

1.0

—

Hypo-osmolality and hyponatraemia

2.81

2.46

1.0

—

Asthma, unspecified (mode)

1.98

2.44

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

143

1.71

2.42

1.0

—

Insulin medication

135

1.84

2.41

1.1

1.0

—

Other arthritis (FG)

2.17

2.40

1.1

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

5.01

2.40

1.0

1.2

—

Diabetes, varying definitions

187

1.60

2.40

1.0

—

Other/unspecified disorders of vestibular function

6.27

2.37

1.4

1.3

—

Other symptoms and signs involving general sensations and perceptions

6.27

2.37

1.0

—

Benign neoplasm of urinary organs

6.26

2.37

1.0

—

Disorders of choroid and retina

136

1.77

2.37

1.1

1.0

—

Benign neoplasm of brain and other parts of central nervous system

3.64

2.36

1.0

1.1

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

4.13

2.36

1.1

—

Tuberculosis, IBD comorbidity

4.12

2.36

1.0

1.1

—

Tuberculosis, wide

4.12

2.36

1.0

1.1

—

Bipolar affective disorders

2.61

2.35

1.2

1.0

—

Other diseases of hard tissues of teeth

140

1.76

2.34

1.1

1.0

—

Other specified/unspecified arthritis

2.26

2.33

1.1

1.0

—

Dental caries 3

140

1.64

2.33

1.0

1.1

—

Dental pulpitis 2

113

1.72

2.32

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

179

1.61

2.32

1.0

—

Zoster [herpes zoster]

2.69

2.27

1.3

1.0

—

Lack of expected normal physiological development

4.77

2.27

1.0

—

Depression or dysthymia

1.83

2.26

1.1

1.0

—

DVT of lower extremities and pulmonary embolism

2.11

2.26

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

3.89

2.25

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

106

1.98

2.24

1.0

—

Suicide or other Intentional self-harm

2.27

2.24

1.1

1.0

—

Mycoses

2.27

2.24

1.0

—

Spondylopathies

101

1.80

2.23

1.0

—

Insulin, intermediate and long-acting

139

1.83

2.22

1.1

1.0

—

Other headache syndromes

2.09

2.22

1.1

1.0

—

Respiratory tuberculosis, not confirmed

5.57

2.21

1.0

1.1

—

Benign neoplasm of urinary organs

5.57

2.21

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

146

1.60

2.19

1.1

1.0

—

Spirochaetal infections, other/unspecified

3.34

2.18

1.0

—

Mixed and other personality disorders

3.34

2.18

1.0

—

Social phobias

3.34

2.18

1.0

—

Disorders of the thyroid gland

180

1.60

2.18

1.0

—

Other diseases of blood and blood-forming organs, wide

2.24

2.17

1.3

1.0

—

Other disorders of urethra and urinary system

139

1.73

2.15

1.1

1.0

—

Dental caries 3 and operation codes

152

1.59

2.15

1.0

1.1

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.30

2.15

1.5

1.0

—

178

1.54

2.13

1.1

1.0

—

Injuries to the head

227

1.52

2.13

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

3.00

2.13

1.1

1.0

—

Acute sinusitis

134

1.81

2.12

1.1

1.0

—

Specific development disorders of scholastic skills

2.97

2.12

1.1

—

Dental operations, only avohilmo

101

1.72

2.11

1.1

1.0

—

Heart failure, not strict

123

1.74

2.11

1.0

—

Finngen Rheumatological endpoints

171

1.57

2.10

1.1

1.0

—

Generalized anxiety disorder

2.71

2.10

1.0

—

Atrial fibrillation and flutter with reimbursement

2.71

2.09

1.0

—

Lymphoid leukaemia

3.21

2.09

1.4

1.0

—

Other disorders of lacrimal gland

2.13

2.08

1.1

1.0

—

Disorders of tooth development and eruption

2.93

2.08

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

154

1.74

2.07

1.1

1.0

—

Heterophoria

2.91

2.07

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

137

1.64

2.06

1.0

—

Other intervertebral disc disorders

114

1.72

2.06

1.0

—

Disorders of gallbladder, biliary tract and pancreas

160

1.61

2.05

1.1

1.0

—

Other necrotizing vasculopathies

3.51

2.05

1.0

1.1

—

Visual impairment including blindness (binocular or monocular)

3.51

2.05

1.3

1.2

—

Hypothyroidism, strict autoimmune

114

1.74

2.05

1.1

1.0

—

127

1.81

2.04

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

201

1.63

2.04

1.0

—

Traumatic subdural haemorrhage

4.92

2.04

1.0

—

Cramp and spasm

4.01

2.04

1.0

1.1

—

Asthma-related pneumonia

1.98

2.04

1.1

—

Asthma, hospital admissions 3, pneumonia

1.98

2.04

1.1

—

Asthma-related pneumonia or sepsis

1.98

2.04

1.1

—

Chronic lower respiratory diseases

220

1.48

2.03

1.0

—

Vocal cord dysfunction

2.88

2.03

1.0

—

Dental caries 3, only avohilmo

146

1.58

2.02

1.0

1.1

—

Other medical care

2.11

2.02

1.2

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.40

2.02

1.1

1.0

—

Hypothyroidism, other/unspecified

165

1.60

2.02

1.1

1.0

—

Other and unspecified tonsillitis

1.95

2.01

1.2

1.0

—

Other and unspecified visual disturbances

3.08

2.01

1.1

1.0

—

Benign neoplasm of other and unspecified endocrine glands

2.63

2.01

1.0

1.1

—

Leiomyoma of uterus

2.01

2.00

1.1

1.0

—

Bleeding

155

1.64

1.99

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

171

1.58

1.98

1.0

—

Poisoning by drugs, medicaments and biological substances

2.14

1.98

1.1

—

Coxibs

2.28

1.97

1.0

—

Asthma, hospital admissions , main diagnosis only

228

1.57

1.97

1.0

—

Intracerebral haemorrhage

3.34

1.96

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.60

1.95

1.1

—

Type 2 diabetes, definitions combined

136

1.62

1.94

1.0

—

Other noninflammatory disorders of uterus, except cervix

0.00

1.94

0.0

1.0

—

Erysipelas

1.95

1.94

1.1

1.0

—

Diagnoses used for exclusion with ILD

2.19

1.94

1.0

—

Rare circulating lymphoid malignancy

3.76

1.93

1.5

1.0

—

Statin medication

106

1.69

1.93

1.1

1.0

—

Non-follicular lymphoma, hilmo, excluding all cancers

3.75

1.93

1.0

1.1

—

Inflammatory disease of uterus

2.97

1.93

1.0

1.1

—

Lung diseases due to external agents

2.73

1.93

1.0

1.1

—

Postpartum care and examination

2.87

1.92

1.2

1.0

—

Other retinal disorders

113

1.78

1.91

1.1

1.0

—

Nonorganic sleeping disorders

2.24

1.90

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

137

1.61

1.90

1.0

—

Other disorders starting during childhood or adolescence

2.55

1.89

1.1

—

Acetic acid derivatives and related substances

2.23

1.88

1.1

1.0

—

Other necrotizing vasculopathies (FG)

3.19

1.88

1.0

—

Seropositive rheumatoid arthritis, strict definition

2.65

1.86

1.0

1.1

—

Other diseases of lip and oral mucosa

2.65

1.86

1.0

—

Benign neoplasm: Stomach

3.53

1.83

1.0

1.1

—

Chronic periapical parodontitis

2.50

1.83

1.0

—

Hemiplegia

4.17

1.82

1.0

1.1

—

Acute upper respiratory infections

191

1.51

1.82

1.1

1.0

—

Budesonide

2.57

1.80

1.0

—

Other shoulder lesions

3.05

1.80

1.0

1.1

—

Disorders of lacrimal system

1.92

1.79

1.1

1.0

—

Benzodiazepine use

196

1.52

1.79

1.0

—

Hypothyroidism, drug reimbursement

2.86

1.78

1.1

1.0

—

Hernia

176

1.54

1.77

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

224

1.53

1.77

1.0

—

Disorders of speech understanding and production

2.71

1.75

1.1

—

Other sexually transmitted chlamydial diseases

3.34

1.74

1.2

1.1

—

Rheumatoid arthritis, including avohilmo

1.93

1.74

1.1

1.0

—

Complications of procedures, not elsewhere classified

186

1.58

1.74

1.0

—

Other disorders of patella

2.50

1.73

1.0

—

Spinal stenosis

1.96

1.73

1.0

—

Disorders of muscles

2.67

1.72

1.0

1.1

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

2.92

1.72

1.1

1.0

—

Osteonecrosis

3.85

1.71

1.0

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

3.85

1.71

1.0

—

Alzheimer disease, excluding more controls

4.17

1.71

1.0

—

Sleep disorders

2.13

1.71

1.0

1.1

—

Antihypertensive medication - note that there are other indications

129

1.57

1.70

1.1

1.0

—

Inflammatory diseases of female pelvic organs

110

1.71

1.70

1.0

—

Recurrent or chronic depression

1.91

1.70

1.1

1.0

—

Melanocytic naevi

2.06

1.69

1.1

1.0

—

Substance abuse

134

1.71

1.69

1.2

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.44

1.69

1.1

1.0

—

Genitourinary diseases

130

1.54

1.68

1.1

1.0

—

Bronchiectasis

3.16

1.66

1.0

1.1

—

Excessive vomiting in pregnancy

3.16

1.66

1.0

1.1

—

Mental disorders, not otherwise specified

2.80

1.65

1.0

1.1

—

Paracetamol of NSAID medication

2.10

1.65

1.3

1.0

—

Hypertensive diseases (excluding secondary)

1.70

1.64

1.1

—

Striking against or struck by other objects

112

1.79

1.63

1.1

—

Lumbar disc prolapse

106

1.72

1.62

1.0

—

Certain conditions originating in the perinatal period

2.10

1.62

1.1

—

Other disorders of ear

172

1.51

1.60

1.0

—

Leiomyoma of uterus

1.73

1.60

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2.50

1.59

1.0

—

Hypopituitarism

2.50

1.59

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

2.20

1.59

1.0

—

IBD patients in KELA-register

2.00

1.59

1.0

1.1

—

Symptoms and signs involving speech and voice

1.95

1.58

1.0

1.1

—

Paralytic strabismus

3.00

1.58

1.0

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

2.69

1.58

1.0

—

135

1.66

1.57

1.2

1.0

—

Procreative management

1.78

1.57

1.1

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.80

1.57

1.1

1.0

—

Cholecystectomy

147

1.62

1.57

1.0

—

Alcohol abuse, main dg

2.20

1.56

1.4

1.1

—

ILD medications: azathioprine

2.20

1.56

1.2

1.0

—

All influenza (not pneumonia)

2.20

1.56

1.1

—

Inflammatory bowel disease

1.85

1.55

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.85

1.55

1.1

1.0

—

Direct fill therapy

2.11

1.54

1.2

1.1

—

Viral pneumonia

2.43

1.53

1.0

—

Speech therapy

1.97

1.53

1.1

1.0

—

Early onset COPD, excluding more controls

2.42

1.53

1.1

1.0

—

Other disorders of teeth and supporting structures

2.27

1.53

1.0

—

Respiratory tuberculosis

3.34

1.52

1.0

1.1

—

Respiratory tuberculosis, confirmed and not-confirmed

3.34

1.52

1.0

1.1

—

Allergic asthma (mode), excluding more controls

2.03

1.52

1.1

1.0

—

Other systemic involvement of connective tissue (FG)

2.09

1.52

1.1

1.0

—

Disorders of eyelid, lacrimal system and orbit

181

1.52

1.1

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.86

1.50

1.0

1.1

—

Abnormalities of heart beat

1.91

1.50

1.2

1.0

—

Infections with a predominantly sexual mode of transmission

1.90

1.48

1.1

1.0

—

Inflammatory bowel disease, strict (require KELA)

1.95

1.48

1.0

1.1

—

Ulcerative colitis

1.95

1.48

1.0

1.1

—

Pulmonary embolism

2.00

1.48

1.0

—

Pulmonary heart disease

2.00

1.48

1.0

—

Mental and behavioural disorders due to psychoactive substance use

138

1.64

1.48

1.2

1.0

—

Agranulocytosis

2.44

1.47

1.1

—

Phobic anxiety disorders

2.43

1.47

1.0

1.1

—

Insomnia

2.22

1.46

1.0

—

Other disorders of eyelid

1.81

1.45

1.0

—

Abnormal findings on diagnostic imaging of lung

1.80

1.44

1.0

—

Other specific joint derangements/joint disorders

156

1.50

1.44

1.0

—

Tuberculosis

3.13

1.44

1.0

1.1

—

Non-follicular lymphoma

2.73

1.43

1.0

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

2.73

1.43

1.0

—

Renal tubulo-interstitial diseases

192

1.48

1.43

1.0

—

Other heart diseases, wide

190

1.44

1.43

1.0

—

Allergic asthma (mode)

1.96

1.41

1.1

1.0

—

Childhood asthma (age<16)

2.30

1.41

1.1

1.0

—

Childhood asthma (age<16), excluding more controls

2.30

1.41

1.1

1.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.67

1.40

1.2

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.79

1.40

1.1

1.0

—

Eating disorders

2.41

1.39

1.0

—

Sciatica+with lumbago

1.77

1.38

1.0

—

Other and unspecified urticaria

1.94

1.38

1.1

—

Covid-19 suspected case

1.94

1.38

1.2

1.1

—

Ulcerative colitis (strict definition, require KELA)

2.00

1.38

1.0

1.1

—

Blepharochalasis

2.00

1.37

1.0

—

Migraine without aura and triptan purchases

2.20

1.36

1.1

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

2.61

1.36

1.0

1.1

—

Nontraumatic intracranial haemmorrhage

2.20

1.36

1.0

—

Infections specific to the perinatal period

2.96

1.36

1.0

1.2

—

KRA_PSY_EATING, excluding more controls

2.60

1.36

1.0

—

Persons encountering health services in circumstances related to reproduction

138

1.52

1.36

1.1

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.15

1.35

1.1

1.0

—

0.00

1.35

0.0

1.1

—

Complications of medical and surgical care

173

1.54

1.35

1.0

—

Diaphragmatic hernia

1.87

1.34

1.0

—

Cholelithiasis

138

1.52

1.33

1.0

—

Enthesopathies of lower limb, excluding foot

2.14

1.33

1.0

—

Disorders of refraction and accommodation

1.75

1.33

1.1

—

Azathioprine

2.04

1.32

1.2

1.1

—

Specific personality disorders

1.97

1.32

1.1

1.0

—

Other joint disorders

161

1.42

1.31

1.0

—

Other infectious diseases

2.50

1.30

1.0

1.1

—

Visual field defects

2.50

1.30

1.0

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

2.50

1.30

1.0

—

Pre-eclampsia

2.09

1.30

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.72

1.29

1.1

1.0

—

Melanocytic naevi

1.84

1.29

1.1

1.0

—

Heart failure and antihypertensive medication

2.12

1.28

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

2.78

1.28

1.2

1.1

—

Use of hypnotics and sedatives

181

1.41

1.28

1.0

—

Myocardial infarction, strict

0.42

1.27

1.0

—

Secondary hypertension

2.75

1.27

1.0

1.1

—

Combinations of oral blood glucose lowering drugs

2.00

1.27

1.0

—

5-aminosalicylic acid

2.00

1.27

1.0

1.1

—

Somatoform disorder

2.29

1.26

1.0

—

Dementia, including avohilmo

1.86

1.24

1.0

—

Convergent concomitant strabismus

2.40

1.24

1.0

1.2

—

Other disorders of bladder

2.40

1.24

1.0

—

Eating disorder

2.40

1.24

1.0

—

Intermittent heterotropia

2.23

1.24

1.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

2.22

1.24

1.1

1.0

—

Pre-eclampsia or eclampsia

2.00

1.23

1.0

—

Fracture at wrist and hand level

100

1.70

1.22

1.1

1.0

—

Artrosis, including avohilmo

132

1.45

1.22

1.0

—

Noninfective enteritis and colitis

155

1.55

1.21

1.0

—

Pneumothorax

2.63

1.21

1.4

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.68

1.21

1.0

—

2.16

1.21

1.3

1.1

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2.16

1.21

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

121

1.62

1.21

1.1

1.0

—

Superficial injury of hip and thigh

2.16

1.21

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.65

1.20

1.0

1.1

—

Atopic dermatitis

160

1.49

1.19

1.0

—

Acute alcohol intoxication

1.83

1.19

1.3

1.1

—

Mental and behavioural disorders due to alcohol

121

1.61

1.19

1.2

1.0

—

Benign neoplasm: Colon

1.77

1.18

1.1

1.0

—

Cholelithiasis, broad definition with cholecystitis

139

1.48

1.18

1.0

—

Other systemic involvement of connective tissue

1.88

1.17

1.1

1.0

—

Urticaria and erythema

117

1.62

1.17

1.1

1.0

—

Alcohol use disorder, Swedish definition

123

1.58

1.17

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.93

1.16

1.0

1.1

—

Haemorrhage from respiratory passages

1.78

1.16

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

141

1.56

1.16

1.1

1.0

—

Chalazion

0.00

1.16

0.0

1.1

—

Scissor bite

0.00

1.16

0.0

1.1

—

Crohn's disease of small intestine

2.50

1.15

1.0

1.2

—

Crushed, pushed or stepped on by crowd or human stampede

2.50

1.15

1.0

1.2

—

Other diseases of urinary system

185

1.37

1.15

1.1

1.0

—

Arthrosis

1.51

1.14

1.0

—

Alcohol use disorder, ICD-based

1.68

1.13

1.1

1.0

—

Bronchitis

206

1.37

1.13

1.1

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.85

1.13

1.0

1.1

—

Mental retardation, excluding more controls

2.46

1.13

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

2.34

1.12

1.0

1.1

—

Rash and other nonspecific skin eruption

2.34

1.12

1.3

1.0

—

Monoamine oxidase A inhibitors

2.34

1.12

1.0

—

Any dementia

1.88

1.12

1.0

—

Nephropathy related operations

2.00

1.12

1.3

1.1

—

Cervicalgia

2.00

1.12

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

1.78

1.10

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

1.78

1.10

1.0

—

Paroxysmal tachycardia

1.85

1.10

1.0

1.1

—

Specific development disorders of speech and language

1.98

1.10

1.1

—

COPD (mode)

1.98

1.10

1.1

1.0

—

Generalized epilepsy

2.38

1.09

1.0

—

Other eating disorders

2.38

1.09

1.0

—

Neuromuscular dysfunction of bladder

2.38

1.09

1.0

—

Mucosal proctocolitis

1.95

1.08

1.0

1.1

—

TMD related operations

1.95

1.08

1.0

—

Complications of surgical and medical care, not elsewhere classified

191

1.39

1.08

1.0

—

Chronic diseases of tonsils and adenoids

163

1.40

1.07

1.0

—

Myocardial infarction

0.48

1.07

1.0

—

Disorders of vestibular function (Vertigo)

104

1.62

1.06

1.1

1.0

—

Dementia

1.84

1.06

1.0

—

Overexertion and strenuous or repetitive movements

2.12

1.05

1.0

1.1

—

External causes of morbidity and mortality

116

1.43

1.05

1.0

—

Covid-19 confirmed case

1.71

1.04

1.0

—

Selective serotonin reuptake inhibitors

158

1.37

1.04

1.0

—

Transient global amnesia

2.27

1.03

1.0

—

Unspecified acute lower respiratory infection

1.96

1.03

1.1

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.63

1.03

1.0

1.1

—

Conductive and sensorineural hearing loss

134

1.45

1.02

1.0

—

Injuries to the ankle and foot

216

1.39

1.02

1.1

1.0

—

Constipation

187

1.38

1.02

1.0

—

Emotional disorders starting during childhood or adolescence

2.05

1.02

1.1

—

Any dementia, excluding more controls

1.86

1.01

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.88

1.00

1.0

1.1

—

Chronic pancreatitis

2.00

1.00

1.0

1.1

—

Other acute lower respiratory infections

164

1.45

0.99

1.1

1.0

—

Temporomandibular joint disorders, including avohilmo

131

1.52

0.99

1.1

1.0

—

Fibroblastic disorders

1.84

0.98

1.0

—

Acute alcohol intoxication, ICD10

1.80

0.98

1.4

1.1

—

Acute pharyngitis

1.82

0.97

1.0

—

Ankylosing spondylitis, ICD10

0.00

0.97

0.0

1.1

—

Transplanted organ and tissue status

1.95

0.97

1.4

1.1

—

Adhesive capsulitis of shoulder

1.95

0.97

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

167

1.38

0.97

1.1

1.0

—

Triptan medication for migraine, single purchase ok

167

1.38

0.97

1.1

1.0

—

Sleep disorders (combined)

184

1.35

0.97

1.0

—

Other heart diseases

113

1.46

0.96

1.0

1.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.92

0.95

1.1

—

Lateral epicondylitis

0.00

0.95

0.0

1.1

—

Diseases of inner ear

122

1.52

0.94

1.1

1.0

—

Assault

1.89

0.94

1.0

—

Open wound of head

139

1.49

0.94

1.0

1.1

—

Acute bronchiolitis

1.76

0.94

1.2

1.0

—

Hypertensive diseases

135

1.38

0.93

1.1

1.0

—

Hypertension

135

1.38

0.93

1.1

1.0

—

Hypoglycaemia, other or unspecified

2.22

0.93

1.0

1.1

—

Benign neoplasm: Stomach

2.22

0.93

1.0

1.1

—

Malignant neoplasm of urinary organs

2.22

0.93

1.0

—

Asthma, including avohilmo

230

1.29

0.92

1.0

—

Persons encountering health services in other circumstances, wide

214

1.29

0.92

1.0

—

Hypertension, essential

122

1.40

0.92

1.1

1.0

—

Tinnitus

1.73

0.92

1.0

—

Other respiratory disorders and diseases

1.73

0.92

1.1

1.0

—

Other diseases of the respiratory system

1.73

0.92

1.1

1.0

—

Divergent concomitant strabismus

2.14

0.91

1.2

1.1

—

Disorders of other endocrine glands

140

1.48

0.91

1.0

—

Atrial fibrillation and flutter

1.80

0.91

1.1

1.0

—

Dental caries 3 and operation codes, only avohilmo

1.48

0.90

1.1

—

Volume depletion

2.07

0.89

1.0

—

Injuries to unspecified part of trunk, limb or body region

2.07

0.89

1.0

1.1

—

Propionic acid derivatives

1.54

0.88

1.1

1.0

—

Reimbursement for rheumatic diseases

160

1.43

0.87

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1.86

0.87

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

194

1.38

0.87

1.0

1.1

—

Dialysis, with operation codes

1.86

0.87

1.3

1.1

—

Acute and transient psychotic disorders

2.00

0.87

1.0

1.1

—

Special screening examination for infectious and parasitic diseases

1.75

0.86

1.1

—

Type 1 diabetes

1.58

0.86

1.1

—

Pregnancy examination and test

1.85

0.86

1.1

1.0

—

Cough

107

1.52

0.85

1.2

1.0

—

False labour

1.67

0.85

1.1

1.0

—

Coronary revascularization (ANGIO or CABG)

0.52

0.85

1.0

—

Exclusions for E4_PCOS_BROAD

1.67

0.84

1.0

1.1

—

Mixed conductive and sensorineural hearing loss

1.94

0.84

1.0

1.1

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

1.94

0.84

1.0

—

Temporomandibular joint disorders

1.94

0.84

1.0

—

Emergency coronary revascularization (for ACS)

0.51

0.84

1.0

—

Asthma/COPD (KELA code 203)

216

1.31

0.84

1.0

—

Other maternal disorders predominantly related to pregnancy

1.47

0.83

1.1

1.0

—

Spondylosis

1.57

0.83

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

145

1.44

0.83

1.0

—

Obesity due to excess calories

129

1.47

0.83

1.0

—

Hypertrophy of breast in women and men

1.74

0.82

1.0

—

Anterior Iridocyclitis

1.69

0.82

1.1

1.0

—

Iridocyclitis

1.69

0.82

1.1

—

Pain in thoracic spine

1.88

0.81

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.70

0.80

1.0

—

Shoulder lesions

104

1.41

0.80

1.0

—

Acute tubulo-interstitial nephritis

145

1.41

0.79

1.0

—

Other follicular disorders

0.00

0.79

0.0

1.0

—

Other diseases of biliary tract

0.00

0.79

0.0

1.1

—

Amputation

0.00

0.79

0.0

1.0

—

Pleural plaque

0.00

0.79

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.79

0.0

1.1

—

Achilles tendinitis

0.00

0.79

0.0

1.0

—

Sequelae of injuries of upper limb

1.82

0.79

1.0

1.1

—

Secondary uncertain malignant neoplasm

1.82

0.79

1.0

1.1

—

Radiculopathy

1.82

0.79

1.0

—

Crohn disease

1.67

0.78

1.0

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.67

0.78

1.0

1.1

—

Supervision of normal pregnancy

1.77

0.78

1.2

1.0

—

Other diseases of anus and rectum

1.67

0.78

1.0

1.1

—

Other pleural conditions

0.00

0.77

0.0

1.1

—

Abnormal spermatozoa

0.00

0.77

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.77

0.0

1.0

—

Other and unspecified anaemias

1.53

0.77

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.77

0.76

1.0

1.1

—

Spondylolisthesis/Spondylolysis

1.77

0.76

1.0

—

Hernia of abdominal wall, postoperative

1.77

0.76

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

140

1.43

0.76

1.0

—

Other psoriatic arthropathies

0.00

0.76

0.0

1.1

—

malignant neoplasm of female genital organs

0.00

0.76

0.0

1.1

—

Ulcer of lower limb, not elsewhere classified

0.00

0.76

0.0

1.0

—

Gestational diabetes (for exclusion)

1.54

0.76

1.1

1.0

—

Mandibular retrognathia

1.76

0.76

1.3

1.0

—

Acute and subacute iridocyclitis

1.70

0.75

1.1

1.0

—

Erosion of teeth, including avohilmo

1.70

0.75

1.2

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

159

1.33

0.75

1.1

1.0

—

Poisoning by medicine

1.64

0.75

1.1

—

Atopic dermatitis, strict definition with reimbursement

104

1.49

0.75

1.0

—

Degenerative diseases of the nervous system

1.71

0.74

1.1

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.09

0.74

1.0

—

Crohn's disease NAS

2.09

0.74

1.0

1.1

—

Pruritus

2.08

0.74

1.0

—

Benign leiomyoma with endometriosis

2.08

0.74

1.2

1.0

—

Use of rivastigmine

2.08

0.74

1.0

—

Pre-eclampsia or poor fetal growth

1.60

0.74

1.2

1.0

—

Other anaemias

1.51

0.73

1.0

—

Maternal care for known or suspected fetal abnormality and damage

1.83

0.73

1.3

1.0

—

Paralytic ileus and intestinal obstruction

1.64

0.73

1.0

—

Unspecified mental disorder

108

1.48

0.73

1.1

1.0

—

Immunodeficiencies

2.00

0.72

1.2

1.1

—

Malignant neoplasm of kidney, except renal pelvis

2.00

0.72

1.0

—

Malignant melanoma of skin

2.00

0.72

1.0

1.1

—

Heartburn

2.00

0.72

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

107

1.48

0.72

1.1

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

214

1.25

0.72

1.1

1.0

—

Diseases of the myoneural junction and muscle

1.80

0.72

1.0

1.1

—

Pregnancy hypertension

1.50

0.72

1.0

—

Diseases of middle ear and mastoid

165

1.34

0.71

1.1

—

Alzheimer disease, including avohilmo

1.58

0.71

1.0

—

Allergic colitis

1.93

0.70

1.0

1.1

—

Ptosis of eyelid

1.92

0.70

1.0

1.1

—

Missing teeth due to accident, extraction or parodontitis

1.92

0.70

1.0

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1.92

0.70

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

109

1.47

0.70

1.1

1.0

—

Urticaria

101

1.49

0.70

1.1

1.0

—

Nasal polyp

1.71

0.70

1.0

—

Diseases of oesophagus, stomach and duodenum

197

1.26

0.69

1.0

—

Dental caries 1 and operation codes, only avohilmo

1.46

0.69

1.1

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

1.46

0.69

1.1

1.0

—

Diseases of the digestive system

126

1.43

0.69

1.0

—

Congenital malformations of the urinary system

1.85

0.68

1.0

1.1

—

Pain associated with micturition

1.85

0.68

1.0

1.1

—

Benign leiomyoma with endometriosis

1.85

0.68

1.2

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.56

0.68

1.2

1.0

—

Sulfasalazine

1.53

0.68

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.59

0.68

1.0

1.1

—

Acute nasopharyngitis (common cold)

1.84

0.68

1.0

—

Seropositive rheumatoid arthritis

1.64

0.68

1.0

—

Diseases of appendix

186

1.32

0.67

1.1

1.0

—

Coxarthrosis

1.47

0.67

1.0

—

Other arrhythmias

123

1.37

0.66

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.53

0.66

1.0

1.1

—

Benign neoplasm: Colon

101

1.45

0.64

1.1

1.0

—

Parodontitis or/and operation codes

111

1.34

0.64

1.1

—

Melanocytic naevi of trunk

1.72

0.64

1.0

—

Polymyalgia rheumatica

1.72

0.64

1.0

—

Supervision of high-risk pregnancy

1.67

0.63

1.3

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

168

1.28

0.63

1.0

—

Other problems related to primary support group, including family circumstances

1.60

0.63

1.2

1.0

—

Primary gonarthrosis, bilateral

0.58

0.62

1.0

—

Recurring oral aphthae, including avohilmo

1.63

0.62

1.1

1.0

—

Continuous positive airway pressure

1.61

0.61

1.1

1.0

—

Astigmatism

1.67

0.61

1.2

—

Status post-ami

0.00

0.61

0.0

1.0

—

Erectile dysfunction

0.00

0.60

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

0.60

0.0

1.1

—

Early onset COPD

1.57

0.60

1.1

1.0

—

Other and unspecified psoriasis

0.00

0.60

0.0

1.1

—

Other inflammatory liver diseases

0.00

0.60

0.0

1.1

—

Idiopathic pulmonary fibrosis

0.00

0.60

0.0

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

169

1.29

0.60

1.1

1.0

—

Ankylosing spondylitis

0.00

0.59

0.0

1.0

—

Uterine polyps

0.00

0.59

0.0

1.0

—

Orchitis and epididymitis

0.00

0.59

0.0

1.1

—

Abdominal aortic aneurysm (AAA)

0.00

0.59

0.0

1.0

—

Medical abortion

1.36

0.59

1.0

—

AV-block

1.76

0.58

1.0

—

Vasomotor rhinitis (mode)

0.00

0.58

0.0

1.1

—

Menorrhagia

1.43

0.58

1.0

—

Haemorrhagic and haematological disorders of fetus and newborn

1.74

0.58

1.0

1.1

—

Other arthrosis

1.41

0.58

1.0

—

Polyp of the female genital tract

0.54

0.57

1.0

—

Coxarthrosis [arthrosis of hip](FG)

1.41

0.57

1.0

—

Perforation of tympanic membrane

1.72

0.57

1.0

—

Other disorders of kidney and ureter

1.72

0.57

1.0

1.1

—

Appendectomy

177

1.31

0.57

1.1

1.0

—

Persons encountering health services in other circumstances

116

0.60

0.57

1.1

—

Hyperparathyroidism

1.69

0.57

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

123

1.38

0.57

1.1

1.0

—

Antenatal screening

1.58

0.57

1.1

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.44

0.57

1.0

—

Aneurysms, operations, SAH

1.67

0.56

1.0

—

Pollen allergy

0.57

0.56

1.0

1.1

—

Other cataract

1.46

0.55

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.56

0.55

1.0

1.1

—

Malignant melanoma

1.62

0.55

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.54

0.55

1.0

—

Cervical disc disorders

1.54

0.55

1.0

—

Outcome of delivery

1.62

0.55

1.2

1.0

—

Persons with potential health hazards related to communicable diseases

147

0.67

0.55

1.0

1.1

—

Gastro-oesophageal reflux disease

156

1.31

0.55

1.0

—

Chronic kidney disease

1.50

0.55

1.0

—

Non-ischemic cardiomyopathy

1.50

0.54

1.0

—

Hypertrophy of breast

1.58

0.54

1.0

1.1

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1.51

0.54

1.0

—

Appendicitis, broad definition

186

1.28

0.54

1.1

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1.57

0.54

1.0

—

Benign lipomatous neoplasm

1.48

0.53

1.1

1.0

—

Aplastic and other anaemias

102

1.39

0.53

1.0

—

Unspecified fall

150

1.32

0.53

1.1

1.0

—

Parodontitis and operation codes

172

1.27

0.53

1.1

1.0

—

Retinal breaks without detachment

1.54

0.53

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.44

0.53

1.1

1.0

—

Chronic gastritis

1.52

0.52

1.0

—

Benign paroxysmal vertigo

1.43

0.52

1.0

—

Molar incisor enamel hypoplasia

1.51

0.52

1.5

1.0

—

Other abnormal products of conception

1.50

0.51

1.0

—

Preparation and fitting of bite rail to mouth

1.50

0.51

1.0

1.1

—

Diseases of salivary glands

1.50

0.51

1.0

—

Gestational [pregnancy-induced] hypertension

1.38

0.50

1.0

—

Hypermetropia

1.46

0.50

1.0

1.1

—

Insulin, fast-acting

118

1.36

0.49

1.1

1.0

—

Pacemaker

1.50

0.49

1.0

—

Other/unspecified seropositive rheumatoid arthritis

1.49

0.49

1.0

—

Seropositive rheumatoid arthritis, wide

1.49

0.49

1.0

—

Degeneration of macula and posterior pole

1.41

0.49

1.0

—

Intracranial injury

157

1.29

0.48

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

1.37

0.48

1.1

1.0

—

Nonsuppurative otitis media

1.36

0.48

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

101

1.38

0.47

1.0

—

Acute laryngitis and tracheitis

1.50

0.47

1.1

1.0

—

Persistent mood disorders

1.49

0.47

1.0

—

Injuries to the neck

1.47

0.47

1.0

1.1

—

Ulcerative colitis, NAS

1.46

0.46

1.0

1.1

—

Irregular menses

104

1.33

0.46

1.0

—

Injury, poisoning and certain other consequences of external causes

108

1.25

0.46

1.0

—

Use of pramipexole

1.43

0.46

1.0

—

Malignant neoplasm of digestive organs

0.62

0.45

1.0

—

Urolithiasis

0.60

0.45

1.0

—

Transport accidents

1.34

0.44

1.0

1.1

—

Acute appendicitis

181

1.25

0.44

1.1

1.0

—

Gout

1.39

0.44

1.0

—

Other diseases of the digestive system

1.40

0.44

1.0

—

GI-bleeding

1.40

0.44

1.0

—

Pregnancy with abortive outcome

1.28

0.44

1.0

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1.37

0.44

1.0

—

Other (seronegative) rheumatoid arthritis, wide

1.37

0.44

1.3

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.41

0.43

1.0

—

Mental retardation

1.61

0.43

1.0

1.2

—

Otalgia

1.61

0.43

1.0

1.1

—

Hypokalaemia

1.61

0.43

1.0

—

Benign neoplasm: Sigmoid colon

1.61

0.43

1.0

—

Cholecystitis

1.61

0.43

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.41

0.42

1.0

—

Asthma and allergy, excluding more controls

1.59

0.42

1.0

—

Asthma and allergy

1.59

0.42

1.0

—

Mental retardation, wide definition

1.56

0.42

1.0

1.2

—

Trochanteric bursitis

1.56

0.42

1.0

1.1

—

Other and unspecified iron deficiency

1.38

0.42

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

1.40

0.42

1.0

—

Substance use, excluding alcohol

1.38

0.41

1.0

—

Preterm labour and delivery

1.38

0.41

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

212

1.19

0.41

1.1

1.0

—

Nutritional anaemias

119

1.31

0.41

1.0

—

Conotruncal defects

0.00

0.41

0.0

1.2

—

Abnormal findings on diagnostic imaging of other body structures

1.52

0.41

1.0

1.1

—

Dermatophytosis

1.52

0.41

1.0

1.1

—

Palmar fascial fibromatosis [Dupuytren]

1.52

0.41

1.0

1.1

—

Maltreatment syndromes

0.00

0.41

0.0

1.1

—

Calcific tendinitis of shoulder

0.00

0.41

0.0

1.1

—

Use of galantamine

0.00

0.41

0.0

1.1

—

Emphysema

0.00

0.41

0.0

1.1

—

Nonischemic cardiomyopathy

0.00

0.41

0.0

1.1

—

Right hemicolectomy

0.00

0.41

0.0

1.1

—

Other and unspecified glaucoma

0.00

0.41

0.0

1.1

—

Malignant neoplasm of bladder

0.00

0.41

0.0

1.0

—

Malignant neoplasm of corpus uteri

0.00

0.41

0.0

1.1

—

Corneal ulcer

1.36

0.41

1.1

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.44

0.40

1.1

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.40

0.0

1.1

—

Oesophagitis

0.00

0.40

0.0

1.1

—

Amputation of toe

0.00

0.40

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.40

0.0

1.1

—

Persistent delusional disorders

0.00

0.40

0.0

1.1

—

Dental pulpitis 1, only avohilmo

211

0.84

0.40

1.0

—

Bitten or struck by other mammals

1.47

0.40

1.0

1.1

—

Parkinson's disease, including avohilmo

1.47

0.40

1.0

—

Osteomyelitis

0.00

0.40

0.0

1.0

—

Artificial joint re-operation

0.00

0.40

0.0

1.1

—

Injury of other and unspecified intrathoracic organs

0.00

0.40

0.0

1.1

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1.46

0.40

1.0

—

Major coronary heart disease event

115

0.75

0.40

1.0

—

Other nutritional deficiencies

182

1.23

0.39

1.0

—

Diseases of external ear

102

0.69

0.39

1.0

—

Hyperkinetic disorders, excluding more controls

1.43

0.39

1.0

—

Open wound of ankle and foot

1.43

0.39

1.0

1.1

—

Need for other prophylactic measures

0.00

0.39

0.0

1.1

—

Carcinoma in situ of skin

0.00

0.39

0.0

1.1

—

Fall on and from ladder

0.00

0.39

0.0

1.0

—

Infections of the skin and subcutaneous tissue

177

1.24

0.39

1.0

—

Contraceptive management

1.33

0.39

1.0

—

Dental caries 2

204

1.19

0.38

1.1

1.0

—

COPD related to multimorbidity

1.38

0.38

1.1

1.0

—

Functional dyspepsia

1.36

0.38

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

1.39

0.38

1.0

1.1

—

Melanocytic naevi of trunk

1.39

0.38

1.0

1.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

1.39

0.38

1.0

1.1

—

Candidiasis

1.39

0.38

1.0

1.1

—

Hypotension

1.39

0.38

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

157

1.24

0.38

1.0

—

Short stature, not elsewhere classified

1.38

0.38

1.2

1.1

—

Deep bite

1.31

0.37

1.2

1.1

—

Unspecific neurodegenerative disorder

1.41

0.37

1.0

—

COPD, hospital admission 2, with asthma infections

1.30

0.37

1.1

1.0

—

Disorders of vitreous body

111

0.71

0.37

1.0

—

Other local infections of skin and subcutaneous tissue

1.35

0.37

1.0

1.1

—

Hyperlipidaemia, other/unspecified

1.39

0.37

1.0

—

Female genital prolapse

0.61

0.36

1.0

—

Insulin, fast-acting or short human

125

1.28

0.36

1.1

1.0

—

Heart failure,strict

1.31

0.36

1.0

—

Conduction disorders

1.27

0.36

1.0

1.1

—

Presence of other functional implants

0.74

0.36

1.0

—

Benign neoplasm: Colon, unspecified

1.46

0.36

1.2

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.62

0.36

1.0

—

Disorders of parathyroid gland

1.44

0.35

1.0

—

Retention of urine

1.39

0.35

1.0

—

All-cause Heart Failure

1.28

0.35

1.0

—

Heart failure, strict

1.28

0.35

1.0

—

Other obstetric conditions, not elsewhere classified

1.34

0.35

1.1

1.0

—

Non-allergic asthma (mode), excluding more controls

1.38

0.34

1.0

—

Hypertensive heart and/or renal disease

1.37

0.34

1.0

—

Non-allergic asthma (mode)

1.35

0.34

1.0

—

Atopic dermatitis, strict definition

124

1.26

0.34

1.0

1.1

—

Excessive attrition of teeth

1.29

0.34

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

1.33

0.33

1.0

—

DVT of lower extremities

1.33

0.33

1.0

—

Keratitis

1.32

0.33

1.1

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.32

0.33

1.0

1.1

—

Other noninfective gastroenteritis and colitis

1.32

0.33

1.0

1.1

—

Iron deficiency anaemia

108

1.28

0.33

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.30

0.33

1.2

1.0

—

Chronic periodontitis, including avohilmo

175

1.18

0.33

1.1

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.32

0.33

1.1

—

Osteopathies and chondropathies

138

1.24

0.32

1.1

1.0

—

Peritonsillar abscess

1.28

0.32

1.0

—

Parodontitis

175

1.18

0.32

1.1

1.0

—

Parodontitis or operation codes

175

1.18

0.31

1.1

1.0

—

Hernia of abdominal wall

110

1.27

0.31

1.0

—

Dental caries 2 and operation codes

204

1.17

0.31

1.1

1.0

—

Gonarthrosis [arthrosis of knee](FG)

107

1.21

0.31

1.0

—

Fracture of lower leg, including ankle

155

1.22

0.31

1.1

1.0

—

Gonarthrosis,primary

132

1.19

0.31

1.0

—

Osteoporosis

1.34

0.31

1.3

1.0

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1.35

0.31

1.0

—

N06DA Anticholinesterases

1.32

0.31

1.0

—

Use of anticholinesterases

1.32

0.31

1.0

—

Fall on same level involving ice and snow

156

1.22

0.30

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.32

0.30

1.1

1.0

—

Fissure and fistula of anal and rectal regions

1.32

0.30

1.0

—

Other fall from one level to another

0.73

0.30

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

116

1.24

0.30

1.1

1.0

—

Dental pulpitis 4, only avohilmo

210

0.87

0.30

1.0

—

Conjunctivitis

228

0.84

0.30

1.1

1.0

—

Gout, FINNGEN

1.30

0.30

1.0

—

Other gastritis (incl. Duodenitis)

1.27

0.30

1.0

—

Acute suppurative otitis media

104

1.26

0.29

1.1

—

Polycystic ovarian syndrome, consortium definition

122

1.19

0.29

1.0

—

Personal history of other diseases and conditions

1.22

0.28

1.1

—

Redundant prepuce, phimosis and paraphimosis

1.22

0.28

1.1

1.0

—

Sub-endpoint used in defining T1D endpoints

110

1.25

0.28

1.1

—

Sulfonylureas

1.30

0.28

1.1

1.0

—

Renal failure

1.26

0.28

1.0

1.1

—

Umbilical hernia

1.29

0.28

1.0

—

Deforming dorsopathies

1.27

0.27

1.1

1.0

—

Obesity

175

1.19

0.27

1.0

—

Obesity and other hyperalimentation

175

1.19

0.27

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

1.25

0.27

1.1

1.0

—

Sequelae of external causes of morbidity and mortality

1.25

0.27

1.0

—

Maternal care for other known or suspected fetal problems

1.22

0.27

1.3

1.0

—

Ischaemic heart disease, wide definition

116

1.19

0.27

1.0

—

Other menopausal disorders

0.69

0.27

1.0

—

Irritable bowel syndrome

1.23

0.27

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.30

0.27

1.1

1.0

—

Congenital malformations of the circulatory system

1.28

0.26

1.0

1.1

—

Unspecified haematuria

1.27

0.26

1.2

1.0

—

Hyperplasia of prostate

1.25

0.26

1.0

—

Deviated nasal septum

1.19

0.26

1.0

—

Superficial injury of lower leg

0.68

0.26

1.0

1.1

—

Psoriasis

0.68

0.26

1.0

—

Medicines for HER+ breast cancer

0.68

0.26

1.0

—

Heart failure and bmi 25plus

1.24

0.26

1.0

—

Actinic keratosis

1.26

0.25

1.0

—

Benign lipomatous neoplasm

1.25

0.25

1.1

1.0

—

Superficial injury of head

1.25

0.25

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

155

1.18

0.25

1.1

1.0

—

Female infertility

0.71

0.24

1.0

—

malignant neoplasm of male genital organs

0.72

0.24

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

1.18

0.24

1.0

—

Retinal detachments and breaks

1.18

0.24

1.0

—

Single delivery by forceps and vacuum extractor

1.38

0.24

1.0

—

Internal derangement of knee

0.73

0.24

1.0

—

Contact with and exposure to communicable diseases

125

0.80

0.23

1.0

1.1

—

Hypoplasia of dental enamel , including avohilmo

1.34

0.23

1.6

1.0

—

Use of other anti-dementia drugs

1.32

0.23

1.0

—

Use of memantine

1.32

0.23

1.0

—

Disorders of synovium and tendon

112

1.21

0.23

1.0

—

Hypertensive Heart Disease

1.28

0.23

1.0

—

Sarcoidosis

1.28

0.23

1.0

1.1

—

Methotrexate

1.28

0.23

1.0

—

Other skin changes

1.28

0.23

1.0

—

Kela-code for severe mental illness

1.24

0.22

1.1

1.0

—

Other diseases of pleura

1.23

0.22

1.2

1.1

—

Diseases of liver

1.25

0.22

1.0

—

Excessive, frequent and irregular menstruation

1.20

0.22

1.0

—

Other benign neoplasms of skin

0.74

0.22

1.0

—

Other chronic obstructive pulmonary disease

1.25

0.22

1.1

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.26

0.22

1.1

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

1.22

0.22

1.0

1.1

—

Lesion of ulnar nerve

1.22

0.22

1.0

—

Open wound of lower leg

1.22

0.22

1.0

1.1

—

Malignant neoplasm of breast, HER-negative

1.22

0.22

1.0

—

Sensorineural hearing loss

120

1.17

0.21

1.0

—

Congenital malformations of cardiac chambers and connections

0.00

0.21

0.0

1.1

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.2

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.21

0.0

1.1

—

Other respiratory diseases principally affecting the interstitium

1.19

0.21

1.0

—

Cerebral palsy

0.00

0.21

0.0

1.0

—

Autism spe

0.00

0.21

0.0

1.3

—

Idiopathic thrombocytopenic purpura

0.00

0.21

0.0

1.0

—

Exposure to other and unspecified animate mechanical forces

0.00

0.21

0.0

1.1

—

Other congenital malformations of face and neck

0.00

0.21

0.0

1.1

—

Occupational exposure to risk-factors

0.00

0.21

0.0

1.1

—

Pneumonia derived septicemia

0.00

0.21

0.0

1.0

—

Other erythematous conditions

0.00

0.21

0.0

1.1

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.21

0.0

1.1

—

Other specified disorders of external ear

0.00

0.21

0.0

1.0

—

Juvenile osteochondrosis

0.00

0.21

0.0

1.0

—

Hidradenitis suppurativa

0.00

0.21

0.0

1.1

—

Hypertrophic cardiomyopathy

0.00

0.21

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

0.21

0.0

1.1

—

Extreme obesity with alveolar hypoventilation

0.00

0.21

0.0

1.2

—

Other and unspecified follicular disorders

0.00

0.21

0.0

1.1

—

Maternal care for cervical incompetence

0.00

0.21

0.0

1.1

—

Other disorders of male genital organs

0.00

0.21

0.0

1.0

—

Follicular lymphoma, hilmo

0.00

0.21

0.0

1.1

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.21

0.0

1.1

—

All dysplastic lesions of the vulva

0.00

0.21

0.0

1.2

—

Malignant neoplasm of ovary

0.00

0.21

0.0

1.1

—

Other and unspecified iridocyclitis

0.00

0.21

0.0

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.21

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

0.21

0.0

1.1

—

Lesion of sciatic nerve

0.00

0.21

0.0

1.1

—

Ankylosing spondylitis, strict definition

0.00

0.21

0.0

1.1

—

Embolic stroke

0.00

0.21

0.0

1.0

—

Other benign neoplasms of uterus

0.00

0.21

0.0

1.2

—

Calculus of lower urinary tract

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, squamous

0.00

0.21

0.0

1.0

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

0.21

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

0.21

0.0

1.1

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

1.1

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Other orthopaedic follow-up care

0.00

0.21

0.0

1.0

—

1.18

0.21

1.0

—

Congenital deformities of feet

0.00

0.21

0.0

1.2

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.21

0.0

1.2

—

Other vitreous opacities

0.00

0.21

0.0

1.2

—

Pyothorax

0.00

0.21

0.0

1.0

—

Medial epicondylitis

0.00

0.21

0.0

1.2

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.21

0.0

1.2

—

LeFortI or BSSRO operation

0.00

0.21

0.0

1.1

—

Complications of the puerperium, not elsewhere classified

0.00

0.21

0.0

1.1

—

Other and unspecified injuries of ankle and foot

0.00

0.21

0.0

1.1

—

Use of selegiline

0.00

0.21

0.0

1.1

—

Femoral hernia

0.00

0.21

0.0

1.2

—

Somnolence, stupor and coma

0.00

0.21

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.21

0.0

1.1

—

Malignant neoplasm of stomach

0.00

0.21

0.0

1.0

—

Glaucoma-related operations

0.00

0.21

0.0

1.1

—

Impotence

0.00

0.21

0.0

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.21

0.0

1.0

—

Female infertility, tubal origin

0.00

0.21

0.0

1.1

—

Polycystic ovarian syndrome

0.00

0.21

0.0

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Osteoporosis with pathological fracture (FG)

0.00

0.21

0.0

1.1

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

1.0

—

Gout, unspecified

1.16

0.21

1.0

—

Benign neoplasm: Sigmoid colon

1.16

0.21

1.0

—

Disorders of conjunctiva

237

0.88

0.21

1.1

1.0

—

Mixed disorders of conduct and emotions

0.00

0.21

0.0

1.2

—

Other salmonella infections

0.00

0.21

0.0

1.2

—

Inflammatory disease of cervix uteri

0.00

0.21

0.0

1.2

—

Carcinoma in situ of skin

0.00

0.21

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

0.21

0.0

1.1

—

0.00

0.21

0.0

1.1

—

Open wound of wrist and hand

122

0.81

0.20

1.0

1.1

—

Cardiac murmurs and other cardiac sounds

1.26

0.20

1.0

1.1

—

Nephrotic syndrome

0.00

0.20

0.0

1.1

—

Benign neoplasm: Skin, unspecified

0.00

0.20

0.0

1.1

—

Benign neoplasm: Skin, unspecified

0.00

0.20

0.0

1.1

—

Scar conditions and fibrosis of skin

0.00

0.20

0.0

1.1

—

Barrett oesophagus

0.00

0.20

0.0

1.1

—

Intestinal malabsorption

0.00

0.20

0.0

1.1

—

Other obstructive and reflux uropathy

0.00

0.20

0.0

1.2

—

Macular hole

0.00

0.20

0.0

1.1

—

Sequelae of injuries of head

0.00

0.20

0.0

1.1

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.20

0.0

1.1

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.1

—

Biological medication for rheuma

1.25

0.20

1.0

—

Acute pancreatitis

1.25

0.20

1.5

1.0

—

Other CVD

1.25

0.20

1.0

—

Disorders of vitreous body and globe

113

0.78

0.19

1.0

—

Triptan medication for migraine, min. 3 purchases

137

1.15

0.19

1.1

1.0

—

Major coronary heart disease event excluding revascularizations

107

0.84

0.19

1.0

—

L04AD Calcineurin inhibitors

1.18

0.19

1.0

1.1

—

Sequelae with surgical and medical care as external cause

1.18

0.19

1.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.18

0.19

1.0

—

Bacterial intestinal infections, IBD co-morbidities

1.18

0.19

1.0

—

Injuries to the elbow and forearm

197

0.87

0.19

1.0

—

Alzheimer disease

1.16

0.19

1.0

—

Artificial joint operation, meniscal resection

147

1.13

0.19

1.0

—

COPD

1.23

0.19

1.1

1.0

—

Ganglion

1.15

0.19

1.0

—

Intestinal stricture

1.23

0.18

1.0

—

Dental pulpitis 4

205

0.91

0.17

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

205

0.91

0.17

1.0

—

Impacted teeth

1.14

0.17

1.0

1.1

—

Dental pulpitis 1

205

0.91

0.17

1.0

—

COPD, hospital admissions

1.21

0.17

1.1

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.12

0.17

1.0

—

Abnormal serum enzyme levels

1.11

0.17

1.0

—

In situ neoplasms

1.11

0.17

1.0

—

Primary open-angle glaucoma

0.76

0.17

1.0

—

Malignant neoplasm of breast, HER-positive

0.75

0.17

1.0

—

Acute appendicitis, no complications

157

1.14

0.17

1.1

1.0

—

Injuries to the wrist and hand

232

1.09

0.16

1.1

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.14

0.16

1.0

—

Alcohol dependence

1.13

0.16

1.0

—

Malignant neoplasm of prostate

0.79

0.16

1.0

—

Heart failure and coronary heart disease

0.78

0.16

1.0

—

Fracture of foot, except ankle

0.77

0.15

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1.10

0.15

1.0

—

COPD, early/later onset

1.19

0.15

1.1

1.0

—

1.09

0.14

1.0

—

Acute bronchitis

116

0.84

0.14

1.0

—

Other and unspecified disorders of vitreous body

0.79

0.14

1.0

—

Glaucoma suspect

0.78

0.14

1.0

—

Other disorders of veins

0.78

0.14

1.0

—

Embedded and impacted teeth

0.81

0.13

1.0

1.1

—

Other and unspecified effects of external causes

0.82

0.13

1.0

1.1

—

Conjunctivitis (acute, non atopic)

0.81

0.13

1.0

—

Tonsillectomy and adenotomy

165

1.10

0.13

1.0

1.1

—

Coronary atherosclerosis

103

0.88

0.13

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.82

0.13

1.0

—

Injuries to the knee and lower leg

225

1.07

0.12

1.1

1.0

—

Ovarian cyst

1.16

0.11

1.1

1.0

—

Varicose veins

115

1.12

0.11

1.0

—

Injuries to the hip and thigh

105

0.87

0.10

1.0

—

Angina pectoris

1.11

0.10

1.0

—

Superficial injury of abdomen, lower back and pelvis

1.14

0.10

1.0

—

Other endocrine disorders

1.12

0.10

1.2

1.1

—

Malignant neoplasm of skin

1.12

0.10

1.0

—

Purpura and other haemorrhagic conditions

1.11

0.09

1.2

1.0

—

Lichen planus, including avohilmo

1.11

0.09

1.0

—

HSIL lesion of the cervix uteri

1.11

0.09

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

1.10

0.09

1.0

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1.07

0.09

1.0

—

Endometriosis ASRM stages 3,4

1.09

0.09

1.0

—

Congenital malformations of cardiac septa

1.07

0.09

1.0

1.1

—

Septal defects

1.06

0.09

1.0

1.1

—

Injury of eye and orbit

1.06

0.09

1.2

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

1.06

0.09

1.0

—

Seborrhoeic keratosis

1.06

0.09

1.0

—

Delivery, wide proxy

1.15

0.09

1.2

1.0

—

Type 1 diabetes, wide definition

1.15

0.09

1.1

—

Oxicams

1.10

0.09

1.0

—

Fitting and adjustment of other devices

1.12

0.09

1.0

—

Sleep apnoea

175

0.93

0.09

1.0

—

Meniscus derangement

0.89

0.09

1.2

1.0

—

Other bacterial intestinal infections

1.11

0.09

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

1.11

0.09

1.0

—

Acute appendicitis, with complications

1.11

0.09

1.0

—

Glucosamine medication

1.13

0.09

1.0

—

Premature rupture of membranes

1.08

0.09

1.0

—

1.08

0.09

1.0

—

Presence of other devices

1.09

0.08

1.0

—

Acute pancreatitis (for exclusion)

1.07

0.08

1.5

1.0

—

Complications predominantly related to the puerperium

1.07

0.08

1.0

—

Other hearing loss

1.05

0.08

1.0

—

Long labour

1.05

0.08

1.0

—

Other disorders of bone

1.05

0.08

1.0

—

severe traumatic brain injury, does not include concussion

1.05

0.08

1.0

—

Benign neoplasm: Colon, unspecified

1.03

0.08

1.2

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

1.11

0.08

1.1

1.0

—

Haemorrhoids and perianal venous thrombosis

0.82

0.08

1.0

—

Voice disturbances

0.81

0.08

1.0

—

Hyperkinetic disorders

0.78

0.08

1.0

1.1

—

Gastroduodenal ulcer

0.78

0.08

1.0

—

Haemorrhage in early pregnancy

1.10

0.08

1.0

—

Gonarthrosis

1.10

0.08

1.0

—

All dysplastic lesions of the cervix uteri

1.09

0.08

1.0

—

Fracture of skull and facial bones

1.08

0.08

1.0

1.1

—

Dysplasia of cervi uteri

1.02

0.08

1.0

—

Colonic or urogenital fistula

1.03

0.07

1.0

—

Postpartum hemorraghe, parous women as controls

0.85

0.07

1.0

1.1

—

Otitis externa

0.81

0.07

1.0

—

Cardiodefibrillation

0.81

0.07

1.0

—

Ischemic heart diseases

122

1.08

0.07

1.0

—

Dental caries 2, only avohilmo

208

1.06

0.07

1.1

1.0

—

Hallux valgus (acquired)

1.05

0.07

1.0

—

Fall on and from stairs and steps

1.07

0.07

1.1

—

Pregnancy, childbirth and the puerperium

1.10

0.07

1.2

1.0

—

Superficial injury of wrist and hand

1.04

0.07

1.1

—

Disorders of breast

109

1.11

0.07

1.0

—

Dental pulpitis 3

0.85

0.07

1.0

1.1

—

Carpal tunnel syndrome

129

0.91

0.07

1.0

—

Unstable angina pectoris

0.85

0.07

1.0

—

In situ neoplasms

0.84

0.07

1.0

—

Non-selective monoamine reuptake inhibitors

0.83

0.07

1.0

—

Childhood allergy (age < 16)

1.13

0.07

1.0

1.1

—

Basal cell carcinoma

0.89

0.06

1.0

—

Rotator cuff syndrome

1.09

0.06

1.0

—

Papulosquamous disorders

103

0.87

0.06

1.0

—

Diabetes mellitus in pregnancy

1.12

0.05

1.1

1.0

—

Single spontaneous delivery

0.90

0.05

1.1

1.0

—

Gonarthrosis, primary, with knee surgery

1.09

0.04

1.0

—

Inguinal hernia

115

0.94

0.04

1.0

1.1

—

Viral and other specified intestinal infections

1.10

0.04

1.1

—

Dental caries 2 and operation codes, only avohilmo

162

0.96

0.03

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

0.93

0.03

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1.09

0.03

1.0

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1.09

0.03

1.0

—

Fracture of shoulder and upper arm

102

1.08

0.03

1.0

—

Malignant neoplasm of breast

0.92

0.02

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

165

0.95

0.02

1.1

1.0

—

Disorders of skin appendages

147

0.95

0.01

1.1

1.0

—

Diseases of arteries, arterioles and capillaries

114

1.05

0.01

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

125

1.04

0.01

1.1

1.0

—

Exposure to other specified factors

228

1.03

0.01

1.1

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.05

0.01

1.1

1.0

—

Injuries to the thorax

106

0.94

0.01

1.0

—

Cystitis

161

1.02

0.00

1.0

—

Suppurative and unspecified otitis media

128

1.04

0.00

1.1

—

Spontaneous abortion

1.04

0.00

1.1

1.0

—

Presence of cardiac and vascular implants and grafts

1.02

0.00

1.0

—

Sleep apnoea, including avohilmo

178

1.02

0.00

1.0

—

Delivery

0.99

0.00

1.1

1.0

—

Coxarthrosis, primary

102

1.02

0.00

1.0

—

Allergic rhinitis

121

0.98

0.00

1.0

—

Glaucoma

108

0.98

0.00

1.0

—

Complications of labour and delivery

0.98

0.00

1.1

1.0

—

Diseases of male genital organs

1.03

0.00

1.1

1.0

—

Malignant neoplasm of breast, HER2-negative

0.99

0.00

1.0

—

Noninflammatory disorders of female genital tract

0.99

0.00

1.1

1.0

—

Vasomotor and allergic rhinitis

124

1.03

0.00

1.0

—

Endometriosis

0.99

0.00

1.1

1.0

—

Mouth breathing

127

1.02

0.00

1.0

—

Fracture of forearm

148

1.01

0.00

1.0

—

Non-rheumatic valve diseases

1.03

0.00

1.0

—

Allergic conjunctivitis

172

0.97

0.00

1.1

1.0

—

Basal cell carcinoma, including avohilmo

0.98

0.00

1.0

—

Erosion and ectropion of cervix uteri

0.00

0.0

1.0

—

Contact with other hot fluids

0.00

0.0

1.4

—

Nontoxic diffuse goitre

0.00

0.0

1.0

—

Alopecia areata

0.00

0.0

1.1

—

Systemic sclerosis, icd10

0.00

0.0

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.01

0.00

1.0

—

Systemic sclerosis (FG)

0.00

0.0

1.1

—

Foreign body in ear

0.00

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

0.0

1.1

—

Testicular dysfunction

0.00

0.0

1.0

—

Other and unspecified mononeuropathies of lower limb

0.00

0.0

1.2

—

Chronic respiratory disease originating in the perinatal period

0.00

0.0

1.0

—

Labour and delivery complicated by fetal stress [distress]

0.98

0.00

1.0

—

Cleft lip, lip and palate or palate

0.00

0.0

1.2

—

Hypoparathyroidism

0.00

0.0

1.3

—

All dysplastic lesions of the vagina

0.00

0.0

1.4

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

Chronic Coagulation defects

0.00

0.0

1.1

—

Complications associated with artificial fertilization

0.00

0.0

1.2

—

Follicular lymphoma

0.00

0.0

1.1

—

Personal history of certain other diseases

0.00

0.0

1.1

—

Operations 2 for CAVS

1.01

0.00

1.0

—

Other immunodeficiencies

0.00

0.0

1.0

—

Dissection of aorta

0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.0

—

Contact with sharp object, undetermined intent

0.00

0.0

1.0

—

Benign neoplasm: Lip

0.00

0.0

1.0

—

Secondary right heart disease

0.00

0.0

1.1

—

Ovarian hyperstimulation (induction)

0.00

0.0

1.2

—

Benign neoplasm: Skin of upper limb, including shoulder

0.00

0.0

1.2

—

Gout, idiopatic and unspecified

0.91

0.00

1.0

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.0

1.1

—

Congenital malformations of uterus and cervix

0.00

0.0

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.00

0.0

1.1

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.0

1.2

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.0

1.0

—

Anomalies of dental arch relationship, including avohilmo

0.97

0.00

1.2

1.1

—

Disorder of external ear, unspecified

0.00

0.0

1.1

—

Systemic sclerosis

0.00

0.0

1.0

—

Torsion of testis

0.00

0.0

1.3

—

Anaemia in chronic diseases classified elsewhere

0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

1.0

—

Congenital malformations of heart and great arteries

0.90

0.00

1.0

1.1

—

LSIL lesion of the vulva

0.00

0.0

1.3

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.2

—

Congenital malformations of spine and bony thorax

0.00

0.0

1.0

—

Diabetic retinopathy

0.97

0.00

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.0

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Right ventricular outflow tract obstruction

0.00

0.0

1.0

—

Cardiovascular disorders originating in the perinatal period

0.00

0.0

1.0

—

Chondrocostal junction syndrome [Tietze]

0.00

0.0

1.3

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.0

1.0

—

Torticollis

0.00

0.0

1.2

—

Fistulae involving female genital tract

0.00

0.0

1.2

—

Type 1 diabetes, strict (exclude DM2)

0.97

0.00

1.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.99

0.00

1.0

—

Chronic mastoiditis

0.00

0.0

1.0

—

Hyperprolactinaemia

0.00

0.0

1.1

—

Alcohol-induced acute pancreatitis

0.00

0.0

1.0

—

Pneumococcal septicemia

0.00

0.0

1.0

—

Superficial injury of neck

0.00

0.0

1.2

—

Complications of genitourinary prosthetic devices, implants and grafts

0.00

0.0

1.2

—

Autoimmune thyroiditis

0.00

0.0

1.0

—

Essential (haemorrhagic) thrombocythaemia

0.00

0.0

1.0

—

Primary biliary cholangitis (PBC)

0.00

0.0

1.0

—

Psoriasis (vulgaris), strict definition

0.00

0.0

1.1

—

Benign neoplasm: Rectosigmoid junction

0.00

0.0

1.1

—

Anankastic personality disorder

0.00

0.0

1.1

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.1

—

Other obstetric trauma

0.00

0.0

1.0

—

Other enthesopathies

0.95

0.00

1.0

—

Other diseases of liver

0.94

0.00

1.0

—

Other congenital malformations of intestine

0.00

0.0

1.0

—

Failed induction of labour

0.00

0.0

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

0.0

1.1

—

Autism spe, excluding more controls

0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.0

—

Localized skin eruption due to drugs and medicaments

0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

0.0

1.0

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.0

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.2

—

Need for immunization against single bacterial diseases

0.00

0.0

1.1

—

Tooth eruption problems

1.00

0.00

1.0

1.1

—

Hereditary corneal dystrophies

0.00

0.0

1.1

—

Congenital malformations of anterior segment of eye

0.00

0.0

1.0

—

Anxious personality disorder

0.00

0.0

1.1

—

Carrier of infectious disease

0.00

0.0

1.1

—

Meralgia paraesthetica

0.00

0.0

1.1

—

0.00

0.0

1.2

—

Pedestrian injured in collision with pedal cycle

0.00

0.0

1.1

—

Congenital malformations and deformations of the musculoskeletal system

0.99

0.00

1.2

1.1

—

Family history of other specific disorders

0.00

0.0

1.1

—

Congenital malformations of ear causing impairment of hearing

0.00

0.0

1.0

—

Hirsutism in women

0.00

0.0

1.2

—

Unspecified event, undetermined intent

0.00

0.0

1.2

—

Congenital malformations of great veins

0.00

0.0

1.2

—

Peripheral retinal degeneration

0.00

0.0

1.0

—

Pericarditis

0.00

0.0

1.1

—

Car occupant injured in other and unspecified transport accidents

1.00

0.00

1.0

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.0

1.0

—

Other acute skin changes due to ultraviolet radiation

0.00

0.0

1.2

—

Exposure to smoke, fire and flames

0.00

0.0

1.0

—

Accidental poisoning by and exposure to alcohol

0.00

0.0

1.0

—

Pneumoconiosis due to asbestos and other mineral fibres

0.00

0.0

1.0

—

Toxic effect of alcohol

0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

0.0

1.1

—

Benign neoplasm: Vulva

0.00

0.0

1.1

—

Other and unspecified intracranial injuries

0.00

0.0

1.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.92

0.00

1.3

1.1

—

Other and unspecified injuries of wrist and hand

0.00

0.0

1.1

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.2

—

Complications of other internal prosthetic devices, implants and grafts

0.00

0.0

1.2

—

Superficial injury of ankle and foot

1.02

0.00

1.0

1.1

—

Other abnormal immunological findings in serum

0.00

0.0

1.2

—

Isolated proteinuria

0.00

0.0

1.1

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.0

—

Other congenital malformations of limb(s)

0.00

0.0

1.0

—

Hirsprung

0.00

0.0

1.0

—

Congenital malformations of oesophagus

0.00

0.0

1.0

—

Congenital malformations of breast

0.00

0.0

1.2

—

Congenital absence, atresia and stenosis of large intestine

0.00

0.0

1.0

—

Obesity related asthma

0.89

0.00

1.0

—

Complex cardiac defects

0.00

0.0

1.0

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.0

1.2

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

0.0

1.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

0.0

1.0

—

Adverse effects, not elsewhere classified

1.01

0.00

1.0

1.1

—

Polyhydramnios

0.00

0.0

1.0

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

0.0

1.0

—

Feeding problems of newborn

0.00

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

1.1

—

Other and unspecified primary disorders of muscles

0.00

0.0

1.0

—

Medical treatment for female infertility

0.85

0.00

1.0

—

Fracture of lumbar spine and pelvis

0.96

0.00

1.0

—

Burn and corrosion of head and neck

0.00

0.0

1.0

—

Burn and corrosion of trunk

0.00

0.0

1.2

—

Obstructed labour due to malposition and malpresentation of fetus

0.96

0.00

1.0

—

Bursitis of shoulder

0.00

0.0

1.3

—

Infective bursitis

0.00

0.0

1.0

—

Other articular cartilage disorders

0.00

0.0

1.0

—

Other and unspecified erythematous conditions

0.00

0.0

1.0

—

Benign neoplasm: Vulva

0.00

0.0

1.3

—

Type 1 diabetes, definitions combined

0.98

0.00

1.0

1.1

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.1

—

ILD-related respiratory insufficiency

0.00

0.0

1.0

—

Coxarthrosis, primary, with hip surgery

1.00

0.00

1.0

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.0

1.3

—

Colitis, primary sclerosing

0.00

0.0

1.0

—

Dental pulpitis 3, only avohilmo

0.98

0.00

1.0

1.1

—

IBD (strict) with PSC

0.00

0.0

1.0

—

Drug-induced cataract

0.00

0.0

1.0

—

Crossbite

0.99

0.00

1.0

1.1

—

Exclusion endpoint for supernumerary teeth

0.00

0.0

1.2

—

Maxillary retrognathism

0.00

0.0

1.4

—

Degeneration of the brain due to alcohol

0.00

0.0

1.0

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Postpartum haemorrhage

1.00

0.00

1.0

—

Crowding of teeth, including avohilmo

0.93

0.00

1.3

1.0

—

Urethritis and urethral syndrome

0.00

0.0

1.0

—

Other disorders of Eustachian tube

0.00

0.0

1.0

—

Disturbance of activity and attention

0.93

0.00

1.0

1.1

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

0.92

0.00

1.0

—

Mandibular retrognathia AND surgery (BSSRO)

0.00

0.0

1.2

—

Nontoxic goitre/thyroid nodule

1.01

0.00

1.0

—

Respiratory conditions due to other external agents

0.00

0.0

1.0

—

Iron deficiency

0.00

0.0

1.2

—

Suppurative otitis media, unspecified

0.00

0.0

1.0

—

Single delivery by caesarean section

1.00

0.00

1.0

—

Hyphaema and other vascular disorders of iris and ciliary body

0.00

0.0

1.0

—

Caries in Clefts patients

0.00

0.0

1.2

—

Ulcer of vagina/vulva

0.00

0.0

1.3

—

Iridocyclitis in diseases classified elsewhere

0.00

0.0

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

1.01

0.00

1.0

—

Cleft palate

0.00

0.0

1.0

—

Calcific aortic valvular stenosis

1.01

0.00

1.0

—

Cutaneous abscess, furuncle and carbuncle

0.90

0.00

1.0

—

Other lesions of median nerve

0.00

0.0

1.2

—

Constitutional tall stature

0.00

0.0

1.0

—

Dependent personality disorder

0.00

0.0

1.2

—

Testicular hypofunction

0.00

0.0

1.0

—

Postmenopausal bleeding

0.97

0.00

1.0

—

Diseases of spleen

0.00

0.0

1.2

—

COPD, hospital admissions 1, only main diagnosis

0.92

0.00

1.1

1.0

—

Carcinoma in situ of skin of ear and external auricular canal

0.00

0.0

1.0

—

Carcinoma in situ of skin of scalp and neck

0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

Other deformities of toe(s)

0.00

0.0

1.0

—

Female infertility, cervigal, vaginal, other or unspecified origin

0.94

0.00

1.0

—

Other disorders of prostate

0.00

0.0

1.0

—

Malignant neoplasm, without specification of site

0.00

0.0

1.0

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

0.0

1.0

—

Golimumab

0.00

0.0

1.1

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

0.91

0.00

1.0

—

Other disorders of iris and ciliary body

0.00

0.0

1.0

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Adenocarcinoma and ductal carcinoma of pancreas

0.00

0.0

1.0

—

D07AA Corticosteroids, weak (group I)

0.97

0.00

1.0

1.1

—

Postpartum hemorraghe, all women as controls

0.90

0.00

1.0

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

0.98

0.00

1.0

—

Adenocarcinoma of pancreas

0.00

0.0

1.0

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Other benign neoplasms of skin

0.98

0.00

1.0

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Serous carcinoma of ovary

0.00

0.0

1.1

—

Heart failure and hypertrophic cardiomyopathy

0.00

0.0

1.0

—

Malignant neoplasm of oesophagus

0.00

0.0

1.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

0.0

1.1

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Amputation of thigh

0.00

0.0

1.0

—

Amputation of foot

0.00

0.0

1.0

—

Mandibular prognathia

0.00

0.0

1.4

—

Calcific aortic valvular stenosis, operated

1.01

0.00

1.0

—

Degeneration of nervous system due to alcohol

0.00

0.0

1.0

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.0

1.4

—

Loose body in joint

0.00

0.0

1.0

—

Other congenital malformations of nervous system

0.00

0.0

1.2

—

Other protozoal intestinal diseases

0.00

0.0

1.2

—

Other and unspecified nail disorders

0.00

-0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS